GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Gene Bio Tech Co Ltd (XKRX:086060) » Definitions » Cyclically Adjusted FCF per Share

Gene Bio Tech Co (XKRX:086060) Cyclically Adjusted FCF per Share : ₩-7.81 (As of Dec. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Gene Bio Tech Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Gene Bio Tech Co's adjusted free cash flow per share for the three months ended in Dec. 2024 was ₩-43.699. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩-7.81 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Gene Bio Tech Co's average Cyclically Adjusted FCF Growth Rate was -118.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Gene Bio Tech Co was 12.30% per year. The lowest was -78.20% per year. And the median was -20.50% per year.

As of today (2025-05-19), Gene Bio Tech Co's current stock price is ₩4165.00. Gene Bio Tech Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2024 was ₩-7.81. Gene Bio Tech Co's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Gene Bio Tech Co was 5432.10. The lowest was 21.41. And the median was 85.45.


Gene Bio Tech Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Gene Bio Tech Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gene Bio Tech Co Cyclically Adjusted FCF per Share Chart

Gene Bio Tech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.73 -11.58 0.81 42.37 -7.81

Gene Bio Tech Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.37 38.22 43.03 -7.58 -7.81

Competitive Comparison of Gene Bio Tech Co's Cyclically Adjusted FCF per Share

For the Packaged Foods subindustry, Gene Bio Tech Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gene Bio Tech Co's Cyclically Adjusted Price-to-FCF Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Gene Bio Tech Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Gene Bio Tech Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Gene Bio Tech Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Gene Bio Tech Co's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-43.699/121.1352*121.1352
=-43.699

Current CPI (Dec. 2024) = 121.1352.

Gene Bio Tech Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201503 214.247 99.721 260.255
201506 -149.368 100.051 -180.846
201509 146.835 100.111 177.672
201512 15.788 100.220 19.083
201603 108.797 100.561 131.056
201606 206.882 100.791 248.641
201609 13.093 101.461 15.632
201612 114.653 101.561 136.750
201703 -89.675 102.851 -105.617
201706 265.097 102.611 312.954
201709 2.179 103.491 2.551
201712 -177.826 102.991 -209.154
201803 325.199 104.101 378.413
201806 -165.278 104.130 -192.269
201809 355.913 105.651 408.078
201812 110.066 104.351 127.770
201903 -153.576 104.491 -178.039
201906 -317.433 104.881 -366.628
201909 -59.600 105.200 -68.628
201912 -43.906 105.121 -50.595
202003 -149.518 105.354 -171.914
202006 -429.776 105.112 -495.292
202009 159.489 106.198 181.922
202012 272.391 105.765 311.975
202103 -180.673 107.357 -203.860
202106 -439.943 107.579 -495.383
202109 183.512 108.759 204.394
202112 -233.830 109.676 -258.260
202203 -245.062 111.848 -265.411
202206 -219.357 114.072 -232.939
202209 25.641 114.715 27.076
202212 -133.662 115.179 -140.574
202303 207.535 116.507 215.779
202306 134.108 117.182 138.632
202309 120.214 118.964 122.408
202312 304.617 118.837 310.508
202403 14.930 120.123 15.056
202406 -262.675 120.007 -265.144
202409 99.362 120.861 99.587
202412 -43.699 121.135 -43.699

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Gene Bio Tech Co  (XKRX:086060) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Gene Bio Tech Co was 5432.10. The lowest was 21.41. And the median was 85.45.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Gene Bio Tech Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Gene Bio Tech Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Gene Bio Tech Co Business Description

Traded in Other Exchanges
N/A
Address
311-3, Gyeongcheon-Ri, Gyeryong-Myeon, Gongju, KOR, 314-831
Gene Bio Tech Co Ltd is a specialized fermentation company which researches, develops, produces, and sells biological resources for use in animal resources, agriculture, food and medicine. It offers functional feed ingredients and additives.

Gene Bio Tech Co Headlines

No Headlines